CDKN1A and melanoma: Indeed, its overexpression causes resistance to apoptosis by hindering the induction of p53 and p21 by cisplatin and by increasing p21 phosphorylation via the activation of AKT, a kinase that has an important role in melanoma initiation and therapeutic resistance [43].